STOCK TITAN

Core Scientific Inc SEC Filings

CORZ NASDAQ

Welcome to our dedicated page for Core Scientific SEC filings (Ticker: CORZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Core Scientific, Inc. filings document its high-density colocation data center business, digital asset mining activities, capital structure and public-company governance. Recent 8-K reports cover operating and financial results, Regulation FD disclosures, campus expansion updates, material agreements, debt financing and direct financial obligations.

The company’s filings also describe common stock and warrant securities listed on the Nasdaq Global Select Market, subsidiary financing arrangements, senior secured notes, credit agreement amendments, executive and accounting-officer governance matters, and annual proxy disclosures for shareholder voting, board matters and compensation programs.

Rhea-AI Summary

Core Scientific, Inc. officer Todd M. Duchene reported open-market sales of 10,000 shares of Common Stock on April 13, 2026, in two transactions pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. The shares were sold at weighted average prices within ranges of $17.94–$18.90 and $18.97–$19.04 per share. Following these sales, Duchene directly holds 2,027,089 shares of Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Core Scientific, Inc. officer Todd M. Duchene sold 10,000 shares of Common Stock in an open-market transaction at a weighted average price of $16.4865 per share. After this sale, he directly holds 2,037,089 shares. The trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, and the shares were sold in multiple transactions at prices ranging from $16.285 to $16.78.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Core Scientific, Inc. Chief Executive Officer Adam Taylor reported equity compensation activity involving performance-based restricted stock units (PSUs) and related tax withholding. On March 31, 2026, he acquired 741,545 shares of Common Stock at $0.00 per share upon vesting and settlement of previously granted PSUs tied to specified performance criteria.

On the same date, 315,307 shares of Common Stock were withheld at $14.96 per share to satisfy withholding tax obligations upon the vesting of restricted stock units, a non–open-market, tax-related disposition. After these transactions, Taylor directly held 4,557,388 shares of Common Stock, reflecting routine compensation and tax-settlement mechanics rather than open-market buying or selling.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Core Scientific, Inc. officer Todd M. Duchene reported a mix of equity compensation and share dispositions. On March 31, he received 216,734 shares of common stock through the settlement of performance-based restricted stock units, while 97,652 shares were withheld to cover tax obligations upon vesting.

On April 1, Duchene sold 10,000 shares of common stock in an open-market transaction at a weighted average price of $15.2523 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly holds 2,047,089 shares of Core Scientific common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CORZ filing a Form 144 notice for the proposed sale of 140,000 shares of Common Stock, reported on 04/01/2026. The filing lists two underlying lots—59,388 shares from a merger/acquisition and 80,612 shares from Restricted Stock Units—that together equal the 140,000 shares.

The filing shows an aggregate amount of $2,094,400.00 and a reported shares outstanding figure of 315,332,655 as of 04/01/2026. The broker-dealer listed is Morgan Stanley Smith Barney LLC (Nasdaq). The notice documents an intended sale by an issuer-related source.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

Core Scientific, Inc. outlines its 2025 shift toward high‑density colocation and AI/HPC infrastructure and seeks stockholder votes at its May 12, 2026 virtual annual meeting. The company expanded its CoreWeave agreement by 70 MW to about 590 MW of contracted capacity across five sites, with projected revenue of more than $10 billion over 12 years.

Across four locations, it advanced over 1 million square feet of data center shell, installed nearly $2 billion of infrastructure and supported more than 5 million labor hours, part of more than $5 billion of infrastructure investment largely expected to be funded by the customer. About 350 MW had been energized, with over 180 MW online and billing.

The proxy statement details three proposals: electing five directors, an advisory say‑on‑pay vote on named executive officer compensation, and ratification of KPMG as auditor. It also describes board independence, committee structure, a new cooperation agreement with Two Seas Capital on adding independent directors, and a revised executive pay program that increases performance‑based equity and links PSU vesting partly to relative total shareholder return.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Core Scientific EVP and CFO James P. Nygaard Jr. reported a tax-withholding disposition of Common Stock. On the stated date, 98,671 shares were withheld at $16.42 per share to satisfy withholding tax obligations upon the vesting of restricted stock units. Following this event, Nygaard directly holds 922,982 shares of Core Scientific Common Stock. This was a mechanical tax payment using shares rather than an open-market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Core Scientific Inc — The Vanguard Group filed Amendment No. 3 to a Schedule 13G/A reporting 0 shares beneficially owned of Common Stock as of 03/13/2026. The filing explains an internal realignment on January 12, 2026 that disaggregated certain Vanguard subsidiaries' holdings from The Vanguard Group, Inc.

The reporting person certifies sole and shared voting and dispositive powers of 0 and states ownership is below 5%. The amendment is signed by Ashley Grim on 03/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Core Scientific, Inc. expanded its short-term credit facility by an additional $500.0 million under an accordion feature, bringing total term loan commitments to $1.0 billion. The company borrowed the full incremental amount at a rate of SOFR plus 250 basis points.

Proceeds from this 364-day facility are expected to be used for general corporate purposes tied to developing data center assets, including equipment purchases, pre-development work, real estate acquisitions and energy procurement for high-density colocation and AI-focused infrastructure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.87%
Tags
current report

FAQ

How many Core Scientific (CORZ) SEC filings are available on StockTitan?

StockTitan tracks 92 SEC filings for Core Scientific (CORZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Core Scientific (CORZ)?

The most recent SEC filing for Core Scientific (CORZ) was filed on April 15, 2026.